| Literature DB >> 31619263 |
Xue Bai1, Guoping Shan1, Ming Chen1, Binbing Wang2.
Abstract
BACKGROUND: Intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) are standard physical technologies of stereotactic body radiotherapy (SBRT) that are used for patients with non-small-cell lung cancer (NSCLC). The treatment plan quality depends on the experience of the planner and is limited by planning time. An automated planning process can save time and ensure a high-quality plan. This study aimed to introduce and demonstrate an automated planning procedure for SBRT for patients with NSCLC based on machine-learning algorithms. The automated planning was conducted in two steps: (1) determining patient-specific optimized beam orientations; (2) calculating the organs at risk (OAR) dose achievable for a given patient and setting these dosimetric parameters as optimization objectives. A model was developed using data of historical expertise plans based on support vector regression. The study cohort comprised patients with NSCLC who were treated using SBRT. A training cohort (N = 125) was used to calculate the beam orientations and dosimetric parameters for the lung as functions of the geometrical feature of each case. These plan-geometry relationships were used in a validation cohort (N = 30) to automatically establish the SBRT plan. The automatically generated plans were compared with clinical plans established by an experienced planner.Entities:
Keywords: Machine learning; Non-small-cell lung cancer radiotherapy planning; Stereotactic body radiotherapy
Mesh:
Year: 2019 PMID: 31619263 PMCID: PMC6796412 DOI: 10.1186/s12938-019-0721-7
Source DB: PubMed Journal: Biomed Eng Online ISSN: 1475-925X Impact factor: 2.819
Studies on knowledge-based automated radiotherapy treatment plans
| Database | Site | Prediction method | Dosimetric parameter predictions | Beam angle predictions | |
|---|---|---|---|---|---|
| Moore [ | 25 IMRT | Head-and-neck prostate | Analytical formulas | Mean doses of esophagus, larynx, parotid gland, bladder and rectum | No |
| Wu [ | 91 IMRT | Head-and-neck | Minimal dose approximation | Dose-volume objectives for head-and-neck organs | No |
| Zhu [ | 198 IMRT | Prostate | Machine learning | DVH of bladder and rectum | No |
| Petit [ | 25 IMRT | Pancreas | Minimal dose approximation | Dose-volume objectives for kidney and liver | No |
| Yang [ | 21 IMRT | Prostate | Linear regression | Rectal dose | No |
| Nwankwo [ | 95 VMAT | Prostate | Machine learning | Uniformity index, | No |
| Wang [ | 80 IMRT | Esophagus | Machine learning | Mean heart dose and mean lung dose | No |
Spearman’s rank correlation test
| Lung dose | Beam angle | ||||
|---|---|---|---|---|---|
| Mean |
|
| Start | Stop | |
|
| |||||
| | 0.747* | 0.693* | 0.731* | –0.033 | –0.099 |
| | 0.000 | 0.000 | 0.000 | 0.717 | 0.273 |
|
| |||||
| | − 0.196* | − 0.205* | − 0.235* | 0.073 | 0.021 |
| | 0.029 | 0.022 | 0.008 | 0.416 | 0.813 |
|
| |||||
| | 0.014 | 0.005 | 0.023 | − 0.077 | -0.124 |
| | 0.876 | 0.953 | 0.795 | 0.396 | 0.168 |
|
| |||||
| | − 0.508* | − 0.519* | − 0.467* | 0.182* | 0.234* |
| | 0.000 | 0.000 | 0.000 | 0.042 | 0.009 |
|
| |||||
| | − 0.241* | − 0.233* | − 0.203* | − 0.432* | − 0.412* |
| | 0.007 | 0.009 | 0.023 | 0.000 | 0.000 |
| OVZPL | |||||
| | 0.654* | 0.639* | 0.583* | − 0.33 | − 0.66 |
| | 0.000 | 0.000 | 0.000 | 0.713 | 0.466 |
| OVZPH | |||||
| | 0.385* | 0.381* | 0.254* | − 0.075 | − 0.061 |
| | 0.000 | 0.000 | 0.004 | 0.404 | 0.496 |
|
| |||||
| | − 0.098 | − 0.154 | − 0.075 | 0.762* | 0.745* |
| | 0.277 | 0.087 | 0.405 | 0.000 | 0.000 |
|
| |||||
| | − 0.100 | − 0.155 | − 0.074 | 0.758* | 0.740* |
| | 0.265 | 0.085 | 0.415 | 0.000 | 0.000 |
|
| |||||
| | − 0.113 | − 0.169 | − 0.106 | 0.756* | 0.729* |
| | 0.211 | 0.059 | 0.240 | 0.000 | 0.000 |
|
| |||||
| | − 0.068 | − 0.114 | − 0.109 | − 0.169 | − 0.078 |
| | 0.449 | 0.207 | 0.225 | 0.059 | 0.385 |
*Significant correlation
Fig. 1Prediction of the gantry angle in the training data sets for model validation
Fig. 2Dose prediction in the training data sets for model validation
Clinical constraints and dose results for various indices
| Index | Constraints | Manual plan | Automated plan | |||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | |||
| PTV | > 45.5 | 48.4 | 0.5 | 48.4 | 0.3 | 0.837 |
| PTV | < 70.0 | 66.7 | 2.5 | 69.8 | 2.1 | 0.594 |
| PTV | – | 58.1 | 1.3 | 58.5 | 1.3 | 0.515 |
| PTV HI | – | 0.31 | 0.04 | 0.32 | 0.03 | 0.478 |
| PTV CI | > 0.8 | 0.87 | 0.04 | 0.88 | 0.03 | 0.157 |
| Bronchus | < 30.0 | 9.3 | 12.5 | 9.8 | 10.7 | 0.841 |
| Esophagus | < 32.5 | 5.9 | 6.0 | 6.5 | 5.8 | 0.472 |
| Spinal | < 30.0 | 9.7 | 5.1 | 8.7 | 4.2 | 0.082 |
| Rib | < 54.0 | 31.6 | 19.9 | 36.6 | 18.1 | 0.005 |
| Heart | < 30.0 | 13.1 | 12.2 | 13.0 | 11.6 | 0.658 |
| Lung | < 5.0 | 3.4 | 1.4 | 3.3 | 1.4 | 0.082 |
| Lung | < 15.0 | 9.7 | 4.3 | 9.2 | 4.1 | 0.050 |
| Lung | < 10.0 | 4.6 | 2.6 | 4.4 | 2.5 | 0.658 |
| Total MU | – | 1078 | 217 | 1054 | 198 | 0.594 |
Fig. 3Boxplot showing the dose difference between the manual and automated plans for each ROI. Positive values represent reduced dose in the automated plan and vice versa
Fig. 4OVZPL, XPL, and YPL demonstration
Fig. 5Flowchart of the major steps in automated planning: a Modeling method. b Use of the two models